From FDA labels and ClinicalTrials.gov

Do GLP-1s help people stop smoking?

Last updated

If your prescriber prescribes one: the lowest self-pay GLP-1 prices now

  • Lowest compounded tirzepatide on a monthly plan, not FDA-approved

    Collective

    $69/mo + $199/yr membership · about $86 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

  • Lowest compounded semaglutide on a monthly plan, not FDA-approved

    Collective

    $59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

  • Lowest FDA-approved, starting dose

    LillyDirect (Eli Lilly)

    from $149/mo

  • Lowest FDA-approved injection, starting dose

    NovoCare (Novo Nordisk)

    $199/fill initially

No current GLP-1 label lists smoking as an approved use, so prescribing one for it would be off-label. Lengsfeld et al. (Dulaglutide): Everyone also took varenicline and had counseling. After 12 weeks, 63% on dulaglutide and 65% on placebo had stopped smoking: no difference. Dulaglutide did prevent weight gain after stopping (-1 kg against +1.9 kg). EClinicalMedicine, 2023 (pubmed.ncbi.nlm.nih.gov/36874396). ClinicalTrials.gov lists 13 trials of these medicines on it: 4 with posted results and 5 recruiting now.

Read from the registry and PubMed every day. The newest update here is Sep 21, 2026.

Published results

What the largest trials on smoking found

Each read in the paper's abstract on Nov 6, 2026. Trials differ in who took part and how long they ran.

Lengsfeld et al.

Dulaglutide · 255 people · No clear benefit · Placebo-controlled randomized trial

Everyone also took varenicline and had counseling. After 12 weeks, 63% on dulaglutide and 65% on placebo had stopped smoking: no difference. Dulaglutide did prevent weight gain after stopping (-1 kg against +1.9 kg).

EClinicalMedicine, 2023 (pubmed.ncbi.nlm.nih.gov/36874396)

Phase 2a trial

Semaglutide · 24 people · Mixed · Placebo-controlled randomized trial

Its main measures, resisting smoking in the lab and cigarettes a day, did not change significantly. Craving fell.

JAMA Netw Open, 2026 (pubmed.ncbi.nlm.nih.gov/42189538)

The registry

Trials on smoking, by medicine

A trial counts when the registry's conditions or title name this, and some study a related question, such as insulin sensitivity in people with the condition. A registered trial shows a question being asked, not that the answer is yes.

MedicineTrialsPosted resultsRecruiting
Semaglutide724
Exenatide310
Dulaglutide100
Liraglutide110
Tirzepatide101
Posted results

What trials on smoking reported

Latest phases and largest trials first. Each result is the first primary outcome as its sponsor posted it to the registry, which is not peer review.

TrialMedicinePhasePeopleResult
NCT02975297Exenatide Once Weekly for Smoking CessationExenatidePhase 1/284Number of Participants Who Self-Reported Abstinence and Who Were Biochemically Verified as Abstinent Via Expired CO Level of ≤ 5ppm (Participants), 6 weeks. Exenatide Plus NRT Plus Counseling: 19; Placebo Plus NRT Plus Counseling: 11.
NCT05520775Semaglutide for Alcohol Use DisorderSemaglutidePhase 248Change in Alcohol Consumed (grams), Baseline (Week 0) to post-medication (Week 8). Semaglutide: -32.72; Sham/Placebo: -6.95.
DALDaily Liraglutide for Nicotine DependenceLiraglutidePhase 240Number of Participants With 7-day Point Prevalence Smoking Abstinence at 12 Weeks Post-Target Quit Date (Participants), Week 18. Smoking Cessation Counseling & Liraglutide: 2; Smoking Cessation Counseling & Placebo: 2.
NCT05530577Effects of Semaglutide on Nicotine IntakeSemaglutidePhase 224Change in Nicotine Self-Administration (Number of cigarettes), Baseline (Week 0) to post-medication (Week 8). Semaglutide: -0.8; Sham/Placebo: -0.5.
Recruiting now

Trials on smoking taking people now

The registry page names each site and who can enroll. Ask your clinician before joining one.

TrialMedicinePhaseExpected to finish
Semaglutide for Smoking Cessation in Patients With Diabetes (clinicaltrials.gov/study/NCT07059377)SemaglutidePhase 3Jul 2027
Impact of Semaglutide on Tobacco Use and Related Health Behaviors (clinicaltrials.gov/study/NCT06986993)SemaglutidePhase 4Jun 30, 2028
Multi-Site Trial of Tirzepatide for Smoking Cessation (clinicaltrials.gov/study/NCT07602699)TirzepatidePhase 2Sep 2028
GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV (clinicaltrials.gov/study/NCT07221214)SemaglutidePhase 2Jan 31, 2030
Semaglutide for Post-Smoking Cessation Weight Management (clinicaltrials.gov/study/NCT06173778)SemaglutidePhase 2Jun 25, 2028
From PubMed

Newest papers on GLP-1s and smoking

  • GLP-1 agonists for smoking cessation and post-cessation weight management: A systematic review and meta-analysis of randomized trials (pubmed.ncbi.nlm.nih.gov/42529623)

    Meta-analysis · Tob Induc Dis · Jul 26, 2026 · Heshmati J et al.

  • GLP-1 receptor agonists and smoking cessation: therapeutic promise beyond glycemia (pubmed.ncbi.nlm.nih.gov/41697556)

    Systematic review · Endocrine · Feb 16, 2026 · Bhaduri G et al. · cited by 2

  • Blood pressure changes during smoking cessation in a randomized, double-blind, placebo-controlled trial of dulaglutide treatment (pubmed.ncbi.nlm.nih.gov/40037282)

    Randomized trial · Eur J Prev Cardiol · Oct 1, 2025 · Beck J et al. · cited by 2

  • Exploring Predictors of Treatment Response to GLP-1 Receptor Agonists for Smoking Cessation (pubmed.ncbi.nlm.nih.gov/39780397)

    Randomized trial · Nicotine Tob Res · Jun 1, 2025 · Yammine L et al. · cited by 9

Listed from Europe PMC as published, newest first. A listing here is not a judgement of a study's quality or a recommendation.

Questions

GLP-1s and smoking: common questions

What did the largest trial on smoking find?

Lengsfeld et al. (Dulaglutide, 255 people): Everyone also took varenicline and had counseling. After 12 weeks, 63% on dulaglutide and 65% on placebo had stopped smoking: no difference. Dulaglutide did prevent weight gain after stopping (-1 kg against +1.9 kg).

Is any GLP-1 FDA approved for smoking?

Not in any current label we read. A prescriber can still use a medicine off-label, but insurance often limits coverage to approved uses, so ask your plan.

Which GLP-1 has been studied most for smoking?

Semaglutide, with 7 registered trials on it, then Exenatide with 3. More trials do not mean better results: read what each posted.

Can I join a trial of a GLP-1 for smoking?

5 trials are recruiting on ClinicalTrials.gov now, listed on this page with their registry pages, which name each site and who can enroll.

Other conditions

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.